Loss-making Burberry today led the FTSE 250 index after better-than-expected results fired up hopes that the “best days are ...

GSK Plc agreed to buy an experimental medicine for as much as $2 billion to shore up its drug pipeline and muscle into the promising field of liver therapies.

GSK plc with its development partner iTeos Therapeutics, Inc., has announced that it is ending the development programme for ...

LONDON] GSK agreed to buy an experimental medicine to treat liver disease for as much as US$2 billion as the UK drugmaker ...